Home Contact About

Government news, all in one place

Topics:

Medicines and Healthcare products Regulatory Agency

MHRA Chief Executive update to MHRA staff on the Pathways clinical trial

Tuesday, 24 March 2026
15:32
news_story
MHRA Chief Executive update to MHRA staff on the Pathways clinical trial
Print Article Share Article Read Aloud
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants.

Following the update published on 27 February 2026, we are publishing, for transparency, a copy of an email sent to all MHRA staff by Chief Executive Lawrence Tallon on 11 March 2026, regarding the Pathways clinical trial.

A copy of the email is available here: MHRA staff email - 11 March 2026 (PDF, 125 KB, 2 pages)

View Original Source

View the original news story on GOV.UK →
Share this article: Twitter Email

Related Articles

More Articles from Medicines and Healthcare products Regulatory Agency →

Foreign, Commonwealth & Development Office We must preserve the land and the people of Palestine so that a two-state solution remains viable: UK statement at the UN Security Council

HM Land Registry Support for clients of PM Law

Environment Agency Greater Manchester agencies unite to tackle waste crime

Medicines and Healthcare products Regulatory Agency MHRA Chief Executive update to MHRA staff on the Pathways clinical trial

Ministry of Defence First ever armed forces commissioner selected to champion service personnel and families

Ministry of Defence New military diplomacy training to upskill specialists in negotiation and languages,?as part of new?Defence?Diplomacy Strategy

Department of Health and Social Care Mann recommendations agreed in consultation on GMC overhaul

Department for Business and Trade Update following negotiations on an enhanced FTA with Switzerland

Marine Accident Investigation Branch Vacancy for a Deputy Chief Inspector of Marine Accidents

Cabinet Office Gareth Davies Appointed as New Home Office Permanent Secretary

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: